Ubs Asset Management Americas Inc Immunome Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Immunome Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 78,344 shares of IMNM stock, worth $665,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,344
Previous 58,193
34.63%
Holding current value
$665,140
Previous $597,000
11.73%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.4MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$64.1 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$45.5 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$37 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$36.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$34.6 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $103M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...